• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Exploration of genes associated with efficacy of DNA methytransferase inhibitors for low risk MDS.

Research Project

Project/Area Number 25860781
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Hematology
Research InstitutionThe University of Tokyo

Principal Investigator

NANNYA Yasuhito  東京大学, 医学部附属病院, 講師 (60451811)

Co-Investigator(Renkei-kenkyūsha) YOSHIMI Akihide  東京大学, 医学部附属病院, 助教 (80609016)
Research Collaborator TSUKAMOTO Ayato  
Project Period (FY) 2013-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords骨髄異形成症候群 / 抵抗性メカニズム / 全エクソームシークエンシング / shRNAライブラリ / 耐性化メカニズム / アザシチジン
Outline of Final Research Achievements

We conducted whole exome sequencing in patients with MDS and detected mutations specifically seen in azacitidine resistant phase, which were further narrowed down according to their functions and structures. Clone evolution during resistance acquisition was also analyzed with deep sequencing. Additionally, we screened responsible genes for azacitidine resistance using shRNA library system. We verified these candidate genes by demonstrating that suppression of the candidate genes conferred resistance to azacitidine in-vitro assays.

Report

(3 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi